ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1128

Inter-relationships Between Multiple Joint Osteoarthritis and Collagen Biomarkers in Men: The Johnston County Osteoarthritis Project

Amanda Nelson1, Liubov Arbeeva1, Duncan Lascelles2, Jordan Renner1, Yvonne Golightly1, Morten Karsdal3, Anne-Christine Bay-Jensen3 and Richard Loeser4, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2North Carolina State University, Raleigh, NC, 3Nordic Bioscience, Herlev, Denmark, 4University of North Carolina, Chapel Hill, NC

Meeting: ACR Convergence 2021

Keywords: Biomarkers, Cohort Study, Collagen, Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Osteoarthritis – Clinical Poster III (1118–1134)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: To determine inter-relationships between blood-based collagen formation and degradation biomarkers and multiple joint osteoarthritis (MJOA) phenotypes in a community-based cohort.

Methods: Data were from Johnston County OA Project participants with baseline (BL, T1/T1*) and follow-up (FU, T2) data, initially selected based on available knee radiographs scored for Kellgren-Lawrence Grade (KLG), and subsequently analyzed for radiographic MJOA outcomes including MJOA-1 (≥1 IP node and ≥2 other sites), MJOA-3 (≥5 joint sites), and MJOA-8 (≥3 joint sites, doi: 10.1016/j.semarthrit.2018.10.001).

Serum biomarkers measured included: neo-epitopes of MMP mediated type I, II, and III collagen degradation (C1M, C2M, and C3M, respectively); neo-epitope of MMP-1 and -8 mediated degradation of C-reactive protein (CRPM); N-terminal pro-peptide of C3 (PRO-C3); c-terminal of released C5 domain C6 α3 chain (PRO-C6); and c-terminus of collagen type X release of C10 from cartilage (Col10neo). These represent putative markers of: fibrosis (PRO-C3, -C6); inflammation (C1M, C3M, CRPM); and cartilage degeneration (C2M, Col10neo). Biomarker values were transformed (Box-Cox) and standardized for scale. Multilevel principal component analysis (mPCA) was performed using 7 biomarkers, age, and BMI at BL and FU. Cluster analysis based on PCA-transformed data was used to search for and descriptively analyze MJOA phenotypes.

Results: Results for 225 men are reported; relationships between biomarkers and MJOA were not observed in women (n=503). At BL, C1M, C3M and CRPM clustered together, as did PRO-C3, PRO-C6 and C2M (Fig 1); Col10neo was distinct. MPCA identified 3 clusters (Fig 2). Cluster 1 had the highest frequencies of MJOA-1, -3, and -8. Cluster 2 had a very low frequency of MJOA-3 and lower frequencies of both MJOA-1 and -8 compared with Cluster 1 (Table 1 and Fig 2). Clusters 2 and 3 demonstrated similar frequencies of MJOA-1. Cluster 3 had intermediate frequencies of MJOA-3 and -8 compared with Clusters 1 and 2.

Men in Cluster 1 were older with a lower BMI compared with the other clusters. This cluster was characterized by higher BL C1M which decreased at FU, higher PRO-C3 at BL and FU, and an increase in Col10neo from BL to FU (i.e., higher but declining inflammation, higher fibrosis, and increasing cartilage degeneration). Men in Cluster 2 were the youngest with intermediate BMI. This cluster had the lowest BL C1M and PRO-C3, which increased at FU; this cluster had the highest C1M at FU (i.e., increasing inflammation). Men in Cluster 3 were of an intermediate age with a much higher BMI. This group had a low BL CRPM and Col10neo, which increased at FU; they also had the highest FU PRO-C6 levels (i.e., low inflammation, increasing cartilage breakdown, and high fibrosis).

Conclusion: This exploratory analysis utilized combinations of collagen and MMP-mediated degradation biomarkers at 2 time points, identifying clusters in men but not women, characterized by different frequencies of MJOA involvement at FU. This work highlights the importance of sex in OA and may provide novel insights into specific biomarkers and their change in different phenotypes of MJOA.


Disclosures: A. Nelson, Lilly, 1; L. Arbeeva, None; D. Lascelles, None; J. Renner, None; Y. Golightly, None; M. Karsdal, Nordic Biosciences, 3, 11; A. Bay-Jensen, Nordic Biosciences, 3, 11; R. Loeser, None.

To cite this abstract in AMA style:

Nelson A, Arbeeva L, Lascelles D, Renner J, Golightly Y, Karsdal M, Bay-Jensen A, Loeser R. Inter-relationships Between Multiple Joint Osteoarthritis and Collagen Biomarkers in Men: The Johnston County Osteoarthritis Project [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/inter-relationships-between-multiple-joint-osteoarthritis-and-collagen-biomarkers-in-men-the-johnston-county-osteoarthritis-project/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inter-relationships-between-multiple-joint-osteoarthritis-and-collagen-biomarkers-in-men-the-johnston-county-osteoarthritis-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology